BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38559048)

  • 1. The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
    Lee F; Nguyen D; Hentenaar I; Morrison-Porter A; Solano D; Haddad N; Castrillon C; Lamothe P; Andrews J; Roberts D; Lonial S; Sanz I
    Res Sq; 2024 Mar; ():. PubMed ID: 38559048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Majority of SARS-CoV-2 Plasma Cells are Excluded from the Bone Marrow Long-Lived Compartment 33 Months after mRNA Vaccination.
    Nguyen DC; Hentenaar IT; Morrison-Porter A; Solano D; Haddad NS; Castrillon C; Lamothe PA; Andrews J; Roberts D; Lonial S; Sanz I; Lee FE
    medRxiv; 2024 Mar; ():. PubMed ID: 38496525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Majority of human circulating IgG plasmablasts stop blasting in a cell-free pro-survival culture.
    Nguyen DC; Saney C; Hentenaar IT; Cabrera-Mora M; Capric V; Woodruff MC; Andrews J; Lonial S; Sanz I; Lee FE
    Sci Rep; 2024 Feb; 14(1):3616. PubMed ID: 38350990
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Majority of human circulating plasmablasts stop blasting: A probable misnomer.
    Nguyen DC; Saney C; Hentenaar IT; Cabrera-Mora M; Woodruff MC; Andrews J; Lonial S; Sanz I; Lee FE
    bioRxiv; 2023 Sep; ():. PubMed ID: 37745615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and plasma cells: Is there long-lived protection?
    Nguyen DC; Lamothe PA; Woodruff MC; Saini AS; Faliti CE; Sanz I; Lee FE
    Immunol Rev; 2022 Aug; 309(1):40-63. PubMed ID: 35801537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFα blockade.
    Geisen UM; Rose R; Neumann F; Ciripoi M; Vullriede L; Reid HM; Berner DK; Bertoglio F; Hoff P; Hust M; Longardt AC; Lorentz T; Martini GR; Saggau C; Schirmer JH; Schubert M; Sümbül M; Tran F; Voß M; Zeuner R; Morrison PJ; Bacher P; Fickenscher H; Gerdes S; Peipp M; Schreiber S; Krumbholz A; Hoyer BF
    J Med Virol; 2022 Dec; 94(12):5780-5789. PubMed ID: 35945627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficient Generation of Spike-Specific Long-Lived Plasma Cells in the Bone Marrow After Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
    Tehrani ZR; Habibzadeh P; Flinko R; Chen H; Abbasi A; Yared JA; Ciupe SM; Lewis GK; Sajadi MM
    J Infect Dis; 2024 Feb; ():. PubMed ID: 38365441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 specific plasma cells acquire long-lived phenotypes in human bone marrow.
    Schulz AR; Fiebig L; Hirseland H; Diekmann LM; Reinke S; Hardt S; Niedobitek A; Mei HE
    EBioMedicine; 2023 Sep; 95():104735. PubMed ID: 37556944
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of immunization with inactivated SARS-CoV-2 vaccine (CoronaVac) and/or SARS-CoV-2 infection on antibody levels, plasmablasts, long-lived-plasma-cells, and IFN-γ release by natural killer cells.
    Bilgin H; Marku M; Yilmaz SS; Karahasan Yagci A; Sili U; Can B; Can Sarinoglu R; Mulazimoglu Durmusoglu L; Haklar G; Sirikci O; Eksioglu Demiralp E
    Vaccine; 2022 Apr; 40(18):2619-2625. PubMed ID: 35339303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvanted SARS-CoV-2 spike protein vaccination elicits long-lived plasma cells in nonhuman primates.
    Prabhakaran M; Matassoli F; Leggat D; Hoover A; Srikanth A; Wu W; Henry AR; Wang J; Lin BC; Teng IT; Schramm CA; Castro M; Serebryannyy L; Jean-Baptiste N; Moore C; Gajjala S; Todd JM; McCarthy E; Narpala S; Francica J; Program VP; Corbett-Helaire KS; Douek DC; Kwong PD; Seder RA; Andrews SF; McDermott AB
    Sci Transl Med; 2024 Jan; 16(728):eadd5960. PubMed ID: 38170789
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased antibody response to influenza vaccine with an enhanced antibody response to subsequent SARS-CoV-2 vaccination in patients with chronic hepatitis B virus infection.
    He T; Ling N; Zhang G; Xiang D; Hu P; Peng M; Cai D; Zhang D; Chen M; Ren H
    Immun Inflamm Dis; 2023 Jan; 11(1):e759. PubMed ID: 36705404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single cell multi-omic reference atlases of non-human primate immune tissues reveals CD102 as a biomarker for long-lived plasma cells.
    Staupe RP; Lodge KE; Thambi N; Toole D; Tamburino AM; Chang D; Howell BJ; Hazuda DJ; Vora KA; Sullivan NL
    Commun Biol; 2022 Dec; 5(1):1399. PubMed ID: 36543997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans.
    Turner JS; Kim W; Kalaidina E; Goss CW; Rauseo AM; Schmitz AJ; Hansen L; Haile A; Klebert MK; Pusic I; O'Halloran JA; Presti RM; Ellebedy AH
    Res Sq; 2020 Dec; ():. PubMed ID: 33398264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors of the bone marrow microniche that support human plasma cell survival and immunoglobulin secretion.
    Nguyen DC; Garimalla S; Xiao H; Kyu S; Albizua I; Galipeau J; Chiang KY; Waller EK; Wu R; Gibson G; Roberson J; Lund FE; Randall TD; Sanz I; Lee FE
    Nat Commun; 2018 Sep; 9(1):3698. PubMed ID: 30209264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Responses to SARS-CoV-2 Vaccination in Young Patients with Anti-CD19 Chimeric Antigen Receptor T Cell-Induced B Cell Aplasia.
    Jarisch A; Wiercinska E; Huenecke S; Bremm M; Cappel C; Hauler J; Rettinger E; Soerensen J; Hellstern H; Klusmann JH; Ciesek S; Bonig H; Bader P
    Transplant Cell Ther; 2022 Jul; 28(7):366.e1-366.e7. PubMed ID: 35472554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein finds additional vaccine-induced epitopes beyond those for mild infection.
    Garrett ME; Galloway JG; Wolf C; Logue JK; Franko N; Chu HY; Matsen FA; Overbaugh JM
    Elife; 2022 Jan; 11():. PubMed ID: 35072628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Affecting Early Antibody Secreting Cell Maturation Into Long-Lived Plasma Cells.
    Nguyen DC; Joyner CJ; Sanz I; Lee FE
    Front Immunol; 2019; 10():2138. PubMed ID: 31572364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Multiple Myeloma through the Biology of Long-Lived Plasma Cells.
    Utley A; Lipchick B; Lee KP; Nikiforov MA
    Cancers (Basel); 2020 Jul; 12(8):. PubMed ID: 32751699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow derived long-lived plasma cell phenotypes are heterogeneous and can change in culture.
    Mujtahedi SS; Yigitbilek F; Benavides X; Merzkani MA; Ozdogan E; Abozied O; Moore NA; Park WD; Stegall MD
    Transpl Immunol; 2022 Dec; 75():101726. PubMed ID: 36183942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study.
    Izikson R; Brune D; Bolduc JS; Bourron P; Fournier M; Moore TM; Pandey A; Perez L; Sater N; Shrestha A; Wague S; Samson SI
    Lancet Respir Med; 2022 Apr; 10(4):392-402. PubMed ID: 35114141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.